Constellation Pharmaceuticals Announces Second-Quarter and Six-Month 2019 Financial Results

    NEXT STORY
    CytomX Therapeutics Announces Second Quarter 2019 Financial Results and Provides Business Update
    PREV STORY
    Verrica Pharmaceuticals Reports Second Quarter 2019 Financial Results
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Akcea and Ionis Announce Initiation of NEURO-TTRansform Phase 3 Clinical Trial for AKCEA-TTR-LRx in Patients with Polyneuropathy Driven by Hereditary TTR Amyloidosis

    author_avatar
    NASDAQ Market News

    Targovax announces the appointment of Michael Bogenstaetter as Chief Business Officer

    Oslo, Norway, 8 January 2018: Targovax ASA ("Targovax" or "the Company"; OSE: TRVX), a ...

    author_avatar
    NASDAQ Market News

    Karyopharm’s Selinexor First-in-Human Phase 1 Clinical Trial Data Published in Journal of Clinical Oncology

    NEWTON, Mass., March 04, 2016 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a clinical-stage ...

    author_avatar
    NASDAQ Market News